Overweight patients waiting for operations could safely use a particular type of weight-loss treatment to reduce the risk of ...

People who took the daily pill orforglipron lost 12 percent of body weight on average after 72 weeks, according to clinical ...

Digestion issues, fatigue, and high costs haven’t stopped some from finding power and transformation through GLP-1 ...

(Reuters) -Doctors advise most patients on GLP-1 obesity drugs such as Wegovy and Zepbound to stay on them to keep the weight ...

One popular health platforms is promoting GLP-1 microdosing for weight loss: But how safe and effective is this approach?

Texas Attorney General Ken Paxton on Tuesday sued U.S. drugmaker Eli Lilly for allegedly “bribing” providers to prescribe its ...

Next-generation weight-loss pills could hit the market in the coming months, with new data raising a key question: Will ...

Drugmaker Eli Lilly says their oral, daily GLP-1 pill, orforglipron, may offer similar weight loss results as weekly GLP-1 ...

近期，娱乐圈内多位长期以丰满形象著称的明星，如贾玲、李雪琴等，纷纷以瘦身新貌亮相，引发了公众对减肥话题的广泛关注。尽管明星们普遍推崇的饮食加运动减肥法对普通人而言挑战重重，一种名为GLP-1的减肥药物却悄然走红，不仅为减肥者提供了新的希望，也吸引了资本市场的热切目光。

Eli Lilly's experimental oral pill, orforglipron, shows promise in obesity treatment, with participants experiencing an ...

In the first Phase 3 trial of its once-daily oral GLP-1 pill in people with obesity, drugmaker Eli Lilly said Thursday that ...

A former college athlete, 51-year-old Charles never thought he'd have to worry about his weight. But football injuries and a ...